Theresa Heah, M.D., MBA is the Chief Medical Officer (CMO) and EVP Operations at AsclepiX Therapeutics. Prior to joining AsclepiX, Dr. Heah served as CMO at Applied Genetic Technologies Corporation (AGTC). Before AGTC, Dr. Heah was Vice President at Aerie Pharmaceuticals, where she was responsible for the development, approval and launches of Rhopressa® and Rocklatan®. Prior to Aerie, Dr. Heah served as Director, Senior Global Medical Affairs leading worldwide launch of EYLEA® followed by the role of Global Strategic Marketing Director EYLEA at Bayer.